Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2014
07/15/2014CA2554436C Use of 14,15-dihydro-20,21-dinoreburnamenin-14-ol for the treatment and/or prevention of serious depression and sleep/waking cycle disorders
07/15/2014CA2552279C Zn2+-chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors
07/15/2014CA2548305C Use of alginate matrices to control cell growth
07/15/2014CA2546959C Composition of herbal extracts for the treatment of atopic dermatitis, skin allergic conditions and acne
07/15/2014CA2505583C Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods
07/15/2014CA2496485C Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis
07/15/2014CA2484303C Salt solution for colon cleansing
07/15/2014CA2420906C Use of a composition comprising an extract of pollen for the treatment of edema
07/15/2014CA2420823C Use of a composition comprising an extract of pollen for the treatment of irritability
07/14/2014DE202012012955U1 Eine Kombination aus mindestens zwei direkt wirkenden antiviralen Wirkstoffen (DAAs) für die Verwendung zur Behandlung von HCV A combination of at least two direct-acting antiviral agents (DAAs) for use in the treatment of HCV
07/13/2014CA2838893A1 Oxygenated demineralized bone matrix for bone growth
07/10/2014WO2014107740A2 Methods for reducing cellular proliferation and treating certain diseases
07/10/2014WO2014107730A2 Use of fatty acid niacin conjugates for treating diseases
07/10/2014WO2014107718A2 Heat shock protein (hsp) inhibition and monitoring effectiveness thereof
07/10/2014WO2014107713A1 Combination of a hdm2 antagonist and a mek inhibitor for use in treating cancer
07/10/2014WO2014107690A1 Biocompatible coating compositions
07/10/2014WO2014107685A2 Compositions and methods for using huperzine and analogs thereof
07/10/2014WO2014107663A2 Compositions and methods for treating cutaneous t cell lymphoma
07/10/2014WO2014107655A1 Use of small molecule unfolder protein response modulators to treat tumors with active sonic hedgehog (ssh) signaling due to smoothened (smo) mutation
07/10/2014WO2014107622A1 Deoxyuridine triphosphatase inhibitors
07/10/2014WO2014107617A1 Delayed-release composition comprising biguanide
07/10/2014WO2014107572A1 Body surface treatment composition and method
07/10/2014WO2014107566A1 Surface binding of nanoparticle based drug delivery to tissue
07/10/2014WO2014107536A1 Boronic acid derivatives and therapeutic uses thereof
07/10/2014WO2014107535A1 Boronic acid derivatives and therapeutic uses thereof
07/10/2014WO2014107531A2 Desensitizing drug products and methods of use
07/10/2014WO2014107379A1 Fluorination of aryl compounds
07/10/2014WO2014107221A1 Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
07/10/2014WO2014107209A2 Crenolanib for treating flt3 mutated proliferative disorders
07/10/2014WO2014107124A1 Treatment of hyperhidrosis
07/10/2014WO2014106988A1 Use of anthocyanin for protecting nerve cells
07/10/2014WO2014106943A1 Medicinal composition containing docetaxel
07/10/2014WO2014106886A1 Cdca5 peptides and vaccines containing the same
07/10/2014WO2014106865A1 Abuse-proofed, extended release pharmaceutical composition comprising tapentadol or a pharmaceutically acceptable salt thereof and processes for preparing thereof
07/10/2014WO2014106861A1 (4e)-4-(4-substituted benzylideneamino)-2,3-dihydro-3- substituted-2-thioxothiazole-5-carbonitriles as a2ar antagonist and process for preparation thereof
07/10/2014WO2014106856A1 Mannose-receptor selective lysinylated cationic amphiphiles and a process for preparation thereof
07/10/2014WO2014106848A1 Coumestan, coumestrol, coumestan derivatives and processes of making the same and uses of same
07/10/2014WO2014106763A1 Pyridopyrazines as anticancer agents
07/10/2014WO2014106762A1 4-pyrimidinylamino-benzenesulfonamide derivatives and their use for the inhibition of polo-like kinase 1 (plk1) for the treatment of cancer and their use for the treatment of bacterial infections
07/10/2014WO2014106741A1 Identifying subjects in need of treatment
07/10/2014WO2014106727A1 Inhaler and formulation
07/10/2014WO2014106660A1 Novel benzodioxane-piperidine derivatives and therapeutic uses thereof for the treatment of neuropsychiatric disorders
07/10/2014WO2014106623A1 C-terminal hsp90 inhibitors to treat pituitary adenomas
07/10/2014WO2014106622A1 1,2,3-triazole-4-amine derivatives for the treatment of sigma receptor related diseases and disorders
07/10/2014WO2014106612A1 Aminopyridine derived compounds as lrrk2 inhibitors
07/10/2014WO2014106606A1 Nove phenyl/pyridine series substitued by hydroxyethylamino for the treatment of cancer
07/10/2014WO2014106473A1 Use of glycyrrhetinic acid or glycyrrhizic acid in preparing medicaments for preventing or treating radiation injury of soft tissue
07/10/2014WO2014093579A3 Crystalline forms of 3-(imidazo[1,2-b] pyridazin-3-ylethynyl)-4-methyl-n-(4-[(4-methylpiperazin-1-yl) methyl]-3-(trifluoromethyl)phenyl)benzamide and its mono hydrochloride salt
07/10/2014WO2014078573A3 Tocopherol and tocopheryl quinone derivatives as correctors of lysosomal storage disorders
07/10/2014WO2014076616A3 Formulations of 5-azacytidine
07/10/2014WO2014074552A3 Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
07/10/2014WO2014066606A3 Combination
07/10/2014WO2014062658A8 Methylene linked quinolinyl modulators of ror-gamma-t
07/10/2014WO2014060941A3 Compounds and compositions of neuroprotective agents for treatment of neurological and neurodegenerative diseases
07/10/2014WO2014060925A3 Compositions and methods for treatment of neurological and neurodegenerative diseases
07/10/2014WO2014057439A3 Compositions and methods for treatment of neurological diseases and its associated complications
07/10/2014WO2014057438A3 Compositions and methods for treatment of cardiovascular diseases
07/10/2014WO2014057080A3 N-(2-(cyclic amine)ethyl)benzamide derivatives as p2x7 inhibitors
07/10/2014WO2014053962A3 Compositions and methods for treatment of diabetes and pre-diabetes
07/10/2014WO2014043230A3 Formulations comprising idebenone, n-acetyl-s-farnesyl-l-cysteine and ergothioneine and uses thereof
07/10/2014WO2013182998A3 Cosmetic and / or pharmaceutical composition for the treatment of skin inflammation and related syndromes
07/10/2014WO2013113746A3 Composition and association of sunscreens for photostabilizing butyl methoxydibenzoylmethane (bmdbm)
07/10/2014WO2013092404A3 Active ingredient combinations of piroctone olamine and one or more physiologically benign hydroxamic acids and also cosmetic or dermatological preparations comprising such active ingredient combinations
07/10/2014US20140194803 Wound-healing compositions and method of use
07/10/2014US20140194677 Estrus synchronization preparations and effective cidr-less protocols
07/10/2014US20140194628 Substituted imidazo ring systems and methods
07/10/2014US20140194614 Amino-lna, thio-lna and alpha-l-oxy-ln
07/10/2014US20140194531 Hydroxytyrosol benefits mitochondria
07/10/2014US20140194528 Usage of sodium houttuyfonate on inhibiting idiopathic pulmonary fibrosis and bleomycin induced pulmonary fibrosis
07/10/2014US20140194527 Geranylgeranylacetone formulations and retinal delivery thereof
07/10/2014US20140194526 Stabilized compositions of volatile alkylating agents and methods of using thereof
07/10/2014US20140194525 Exo-s-mecamylamine formulation and use in treatment
07/10/2014US20140194524 Methods for Treating Alzheimer's Disease
07/10/2014US20140194523 Desensitizing drug products and methods of use
07/10/2014US20140194521 Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis
07/10/2014US20140194519 Antiseptic compositions, methods and systems
07/10/2014US20140194518 Antiseptic compositions, methods and systems
07/10/2014US20140194517 Treatment of Graft-Versus-Host Disease Disorders using RAR Antagonists
07/10/2014US20140194516 Medicaments Containing Pantothenic Acid
07/10/2014US20140194515 Use of a Composition Comprising an Antacid, a Mucolytic and a Gelling Agent in the Treatment of Cold
07/10/2014US20140194514 Topical formulations
07/10/2014US20140194512 Compositions comprising docosapentaenoic acid and methods of use
07/10/2014US20140194511 Dietary formulations and methods for treatment of inflammation and other disorders
07/10/2014US20140194510 Dispersions of rasagiline citrate
07/10/2014US20140194506 Use of Potassium Piperonyl Pentadienoate for Lowering Blood Lipid
07/10/2014US20140194504 Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract
07/10/2014US20140194503 Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract
07/10/2014US20140194502 Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract
07/10/2014US20140194500 Methods For Treating of SARS
07/10/2014US20140194496 Methods and compositions for inhibiting integrins using tellurium-containing compounds
07/10/2014US20140194489 Compositions and methods for inhibiting expression of tmprss6 gene
07/10/2014US20140194488 Modulation of radiation response using microrna
07/10/2014US20140194487 Novel Formulation of Indomethacin
07/10/2014US20140194486 Therapeutic agents
07/10/2014US20140194485 Isotopologues of isoindole derivatives
07/10/2014US20140194484 Method of Treating Cachexia and Sarcopenia
07/10/2014US20140194482 Compositions and methods of treatment of inflammatory skin conditions using allantoin
07/10/2014US20140194479 Compositions and methods for treating mood disorders
07/10/2014US20140194477 Kinase protein binding inhibitors
07/10/2014US20140194476 Pyridone derivatives and their use in the treatment, ameloriation or prevention of a viral disease
1 ... 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 ... 7860